Account wins from the 06/13/06 News Brief

Share this article:
Noonan Russo has reported the addition of two California biopharmaceutical companies -- Ambrx and Aerovance -- to its client roster.The agency will develop and implement integrated communications programs to raise the companies’ profiles among prospective investors, business partners and employees.  Program activities will consist of message development, key opinion leader outreach, investor identification and targeting, and media relations.Ambrx is a San Diego-based biopharmaceutical company focused on optimizing existing protein drugs. Aerovance is a Berkeley, Calif.-based company that is focused on the development and commercialization of biologics for respiratory and inflammatory diseases. Interlink Healthcare Communications has undertaken a new assignment for Enzon Pharmaceuticals, as agency of record for Oncaspar, which treats acute lymphoblastic leukemia (also called acute lymphocytic leukemia or ALL), the most common form of cancer in children. The agency will handle promotional communications, primarily directed toward sales force-driven promotion; creative execution for journal ads, direct-to-physician communications, and possibly patient and advocacy communications.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.